Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC

BACKGROUND: We derived estimates of overdiagnosis by polygenic risk groups and examined whether polygenic risk-stratified screening for prostate cancer reduces overdiagnosis. METHODS: We calculated the polygenic risk score based on genotypes of 66 known prostate cancer loci for 4967 men from the Fin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pashayan, Nora, Pharoah, Paul DP, Schleutker, Johanna, Talala, Kirsi, Tammela, Teuvo LJ, Määttänen, Liisa, Harrington, Patricia, Tyrer, Jonathan, Eeles, Rosalind, Duffy, Stephen W, Auvinen, Anssi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651137/
https://www.ncbi.nlm.nih.gov/pubmed/26291059
http://dx.doi.org/10.1038/bjc.2015.289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651137/
https://www.ncbi.nlm.nih.gov/pubmed/26291059
http://dx.doi.org/10.1038/bjc.2015.289

Ejemplares similares